Danaher
Danaher is a diversified business that designs, manufactures and sells laboratory equipment, consumables and services to clinical and medical laboratories including microscopes, analytical software and imaging and molecular devices. These tools are used in the development of new drugs and for diagnosing critically ill patients.
Visit their site- Enterprise value
- US$183.6 bn
- Region
- USA
- Theme
- Health
- Sub-theme
- Research and diagnostics
Impact Score
Danaher provides test and measurement equipment for drug R&D, diagnosis, environment testing, food and water testing and academic research. The company’s products have a wide range of positive impacts. However, these may be incremental for example, through speeding up research and development or increasing efficiency and accuracy.
Fundamental Quality
Danaher has a strong market position as one of two major life science platforms. It has a focused management team and a clear, proven approach to operational improvements (known as the ‘Danaher Business System’). The company has focused its portfolio in recent years on the healthcare sector and has ambitious executive officer performance goals and an improving approach to environmental, social and governance issues.
UN SDGs
Danaher’s products provide the foundations for research and development of new and improved healthcare therapies supporting the achievement of SDG 3.
Find out moreRisk of negative impacts
- Generation of plastics waste from single-use products and packaging
- Use of large amounts of water and chemicals in sterilisation and diagnostics
- Electronic waste at end of life
Related insights Related
Sustainable
The next constraint on AI is not just energy, it's also water
By Ty Lee
10 Mar 2026 | 3 min read
Sustainable
From villain to saviour – renewable energy is coming to the rescue
By WHEB Investment Team
17 Feb 2026 | 6 min read
Sustainable
Are EVs really rolling backwards?
By WHEB Investment Team
19 Jan 2026 | 5 min read
Sustainable
Sustainable investment trends for 2026
By Seb Beloe
19 Jan 2026 | 5 min read